The prevalence of nonalcoholic fatty liver disease (NAFLD) in the United States is 38%,
having increased by 50% within the past 3 decades. The estimated NAFLD prevalence …

Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver
condition in Western World and across the globe. NAFLD prevalence is estimated to be …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the leading liver disease globally.
NAFLD patients can have a progressive phenotype, non-alcoholic steatohepatitis (NASH) …

Prevalence of nonalcoholic fatty liver disease (NAFLD) has risen throughout the world with
urbanization, economic prosperity, and increasing obesity; it is now the commonest chronic …

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of liver disease worldwide,
with rising rates in parallel to those of obesity, type 2 diabetes, and metabolic syndrome …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. NAFLD is defined by excess fat in the liver and has a multidirectional relationship …

Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic fat
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …

Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver
disease in the United States and worldwide. With obesity being an important risk factor …

Background Nonalcoholic fatty liver disease (NAFLD) is a common diagnosis in clinical
practice. Insulin resistance and oxidative stress play an important role in NAFLD …